Cargando…

Expression of the luteinizing hormone receptor (LHR) in ovarian cancer

We investigated the association of LHR expression in epithelial ovarian cancer (OC) with clinical and pathologic characteristics of patients. LHR expression was examined immunohistochemically using tissue microarrays (TMAs) of specimens from 232 OC patients. Each sample was scored quantitatively eva...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiong, Shigang, Mhawech-Fauceglia, Paulette, Tsao-Wei, Denice, Roman, Lynda, Gaur, Rajesh K., Epstein, Alan L., Pinski, Jacek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857310/ https://www.ncbi.nlm.nih.gov/pubmed/31729966 http://dx.doi.org/10.1186/s12885-019-6153-8

Ejemplares similares

Autoimmunity to the Follicle-Stimulating Hormone Receptor (FSHR) and Luteinizing Hormone Receptor (LHR) in Polycystic Ovarian Syndrome
por: Schniewind, Hanna A., et al.
Publicado: (2021)

Identification and Characterization of a Luteinizing Hormone Receptor (LHR) Homolog from the Chinese Mitten Crab Eriocheir sinensis
por: Yuan, Li-Juan, et al.
Publicado: (2019)

Multiple luteinizing hormone receptor (LHR) protein variants, interspecies reactivity of anti-LHR mAb clone 3B5, subcellular localization of LHR in human placenta, pelvic floor and brain, and possible role for LHR in the development of abnormal pregnancy, pelvic floor disorders and Alzheimer's disease
por: Bukovsky, Antonin, et al.
Publicado: (2003)

MET/HGF Signaling Pathway in Ovarian Carcinoma: Clinical Implications and Future Direction
por: Mhawech-Fauceglia, Paulette, et al.
Publicado: (2012)

Characteristics of ovarian tumors of low malignant potential in BRCA mutation carriers: A case series
por: Matsuo, Koji, et al.
Publicado: (2015)

Bilateral Ovarian Serous Borderline Tumor with Non-Invasive Endometrial Implants
por: Malham, Melissa Bou, et al.
Publicado: (2023)

Signal Transduction of Eel Luteinizing Hormone Receptor (eelLHR) and Follicle Stimulating Hormone Receptor (eelFSHR) by Recombinant Equine Chorionic Gonadotropin (rec-eCG) and Native eCG
por: Byambaragchaa, Munkhzaya, et al.
Publicado: (2018)

The prognostic significance of GRB7 protein expression and localization in human breast and ovarian cancers
por: Vermehren-Schmaedick, Anke, et al.
Publicado: (2020)

Phylogenetic Diversity of Lhr Proteins and Biochemical Activities of the Thermococcales aLhr2 DNA/RNA Helicase
por: Hajj, Mirna, et al.
Publicado: (2021)

Paratubal serous borderline tumor in an 85 years old woman: A case report
por: Mehawej, Jordy, et al.
Publicado: (2020)

A Phase II Trial of a Combination Herbal Supplement for Men with Biochemically Recurrent Prostate Cancer
por: Dorff, Tanya B., et al.
Publicado: (2014)

Lhb(−/−)Lhr(−/−) Double Mutant Mice Phenocopy Lhb(−/−) or Lhr(−/−) Single Mutants and Display Defects in Leydig Cells and Steroidogenesis
por: Liu, Zhenghui, et al.
Publicado: (2022)

Subcellular localization of FANCD2 is associated with survival in ovarian carcinoma
por: Joshi, Sonali, et al.
Publicado: (2020)

Association of the genetic variants of luteinizing hormone, luteinizing hormone receptor and polycystic ovary syndrome
por: Liu, Nana, et al.
Publicado: (2012)

Characterization of Luteinizing Hormone and Luteinizing Hormone Receptor and Their Indispensable Role in the Ovulatory Process of the Medaka
por: Ogiwara, Katsueki, et al.
Publicado: (2013)

Elevated Expression of the Serine-Arginine Protein Kinase 1 Gene in Ovarian Cancer and Its Role in Cisplatin Cytotoxicity In Vitro
por: Odunsi, Kunle, et al.
Publicado: (2012)

Endometrioid adenocarcinoma associated with endometrial stromal sarcoma: A rare, often unrecognized collision tumor
por: Kim, Grace, et al.
Publicado: (2015)

BRCAness Profile of Sporadic Ovarian Cancer Predicts Disease Recurrence
por: Wysham, Weiya Z., et al.
Publicado: (2012)

Clinicopathological significance of endoplasmic reticulum stress proteins in ovarian carcinoma
por: Samanta, Soma, et al.
Publicado: (2020)

Lower extremity pain as initial presentation of cervical cancer()
por: Dandapani, Savita V., et al.
Publicado: (2013)

The PAX8 cistrome in epithelial ovarian cancer
por: Adler, Emily K., et al.
Publicado: (2017)

Molecular Analysis of Mixed Endometrioid and Serous Adenocarcinoma of the Endometrium
por: Lawrenson, Kate, et al.
Publicado: (2015)

Validity and prognostic significance of sperm protein 17 as a tumor biomarker for epithelial ovarian cancer: a retrospective study
por: Brunette, Laurie L., et al.
Publicado: (2018)

Regulation of gene expression in ovarian cancer cells by luteinizing hormone receptor expression and activation
por: Cui, Juan, et al.
Publicado: (2011)

Functional conservation of the Drosophila hybrid incompatibility gene Lhr
por: Brideau, Nicholas J, et al.
Publicado: (2011)

Mechanistic insights into Lhr helicase function in DNA repair
por: Buckley, Ryan J., et al.
Publicado: (2020)

DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer
por: Zhang, Wa, et al.
Publicado: (2015)

Claudin7 and moesin in endometrial Adenocarcinoma; a retrospective study of 265 patients
por: Mhawech-Fauceglia, Paulette, et al.
Publicado: (2012)

Expression of protein disulfide isomerase family members correlates with tumor progression and patient survival in ovarian cancer
por: Samanta, Soma, et al.
Publicado: (2017)

Targeting Src in endometriosis-associated ovarian cancer
por: Manek, R, et al.
Publicado: (2016)

Intersection of DNA Repair Pathways and the Immune Landscape Identifies PD-L2 as a Prognostic Marker in Epithelial Ovarian Cancer
por: Batman, Samantha, et al.
Publicado: (2021)

Variant-beta luteinizing hormone is not associated with poor ovarian response to controlled ovarian hyperstimulation
por: Hanevik, Hans I, et al.
Publicado: (2014)

Ovarian stimulation with luteinizing hormone supplementation: the impact of timing on ovarian response and ICSI outcomes
por: Setti, Amanda, et al.
Publicado: (2023)

Genetic Models for the Study of Luteinizing Hormone Receptor Function
por: Narayan, Prema
Publicado: (2015)

Ovarian Function Suppression With Luteinizing Hormone-Releasing Hormone Agonists for the Treatment of Hormone Receptor-Positive Early Breast Cancer in Premenopausal Women
por: Lu, Yen-Shen, et al.
Publicado: (2021)

Expression and Immune Responses to MAGE Antigens Predict Survival in Epithelial Ovarian Cancer
por: Daudi, Sayeema, et al.
Publicado: (2014)

Serum luteinizing hormone level and luteinizing hormone/follicle-stimulating hormone ratio but not serum anti-Müllerian hormone level is related to ovarian volume in Korean women with polycystic ovary syndrome
por: Chun, Sungwook
Publicado: (2014)

Microarray Analysis Reveals Distinct Gene Expression Profiles Among Different Tumor Histology, Stage and Disease Outcomes in Endometrial Adenocarcinoma
por: Mhawech-Fauceglia, Paulette, et al.
Publicado: (2010)

Heme Uptake by Leishmania amazonensis Is Mediated by the Transmembrane Protein LHR1
por: Huynh, Chau, et al.
Publicado: (2012)

Ovarian Cancer Spheroid Cells with Stem Cell-Like Properties Contribute to Tumor Generation, Metastasis and Chemotherapy Resistance through Hypoxia-Resistant Metabolism
por: Liao, Jianqun, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_rlf58chvgg42juev4227f88goj